NEXTURNBIOSCIENCE Co., LTD
089140 | KO
Overview
Corporate Details
- ISIN(s):
- KR7089140008
- LEI:
- Country:
- South Korea
- Address:
- 경기도 용인시 기흥구 기흥단지로121번길 35 (고매동), 용인시
- Website:
- http://www.nexturn.co.kr
- Sector:
- Professional, scientific and technical activities
- Industry:
- Research and experimental development on natural sciences and engineering
Description
No description available.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
You have of free filing views remaining.
Upgrade for unlimited access.
Bulk Actions:
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-08-26 00:00 |
Capital/Financing Update
전환사채(해외전환사채포함)발행후만기전사채취득
|
Korean | 9.5 KB | ||
| 2025-08-25 00:00 |
Share Issue/Capital Change
[기재정정]주요사항보고서(전환사채권발행결정)
|
Korean | 107.5 KB | ||
| 2025-08-25 00:00 |
Share Issue/Capital Change
[기재정정]주요사항보고서(유상증자결정)
|
Korean | 69.6 KB | ||
| 2025-08-14 00:00 |
Interim / Quarterly Report
반기보고서 (2025.06)
|
Korean | 1.5 MB | ||
| 2025-08-07 00:00 |
Share Issue/Capital Change
전환가액의조정
|
Korean | 10.1 KB | ||
| 2025-08-07 00:00 |
Capital/Financing Update
전환사채(해외전환사채포함)발행후만기전사채취득
|
Korean | 9.5 KB | ||
| 2025-08-01 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
|
Korean | 86.1 KB | ||
| 2025-07-30 00:00 |
Share Issue/Capital Change
전환청구권행사
|
Korean | 9.1 KB | ||
| 2025-07-28 00:00 |
Share Issue/Capital Change
전환가액의조정
|
Korean | 10.7 KB | ||
| 2025-07-16 00:00 |
Share Issue/Capital Change
[기재정정]주요사항보고서(자기전환사채매도결정)
|
Korean | 62.7 KB | ||
| 2025-07-16 00:00 |
M&A Activity
주요사항보고서(회사합병결정)
|
Korean | 95.5 KB | ||
| 2025-07-16 00:00 |
Pre-Annual General Meeting Information
주주총회소집결의
|
Korean | 6.0 KB | ||
| 2025-07-16 00:00 |
Pre-Annual General Meeting Information
주주명부폐쇄기간또는기준일설정
|
Korean | 4.1 KB | ||
| 2025-07-16 00:00 |
Pre-Annual General Meeting Information
주주명부폐쇄기간또는기준일설정
|
Korean | 4.7 KB | ||
| 2025-07-03 00:00 |
M&A Activity
합병등종료보고서(합병)
|
Korean | 21.8 KB |
Automate Your Workflow. Get a real-time feed of all NEXTURNBIOSCIENCE Co., LTD filings delivered via API.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
Unlock Full Financials for NEXTURNBIOSCIENCE Co., LTD
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for NEXTURNBIOSCIENCE Co., LTD via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
Company
Country
Ticker
View
Developing a local drug delivery platform to treat KRAS-driven cancers and solid tumors.
United States of America
SLXN
United States of America
SLXN
South Korea
215600
Develops novel cyanobacteria-based payloads for Antibody-Drug Conjugates to treat cancer.
Sweden
SIMRIS
Sweden
SIMRIS
Clinical-stage biotech developing a CB1-inhibiting antibody for obesity and metabolic diseases.
United States of America
SKYE
United States of America
SKYE
%20Co.%2C%20Ltd/other/SLSBioSpecialty_Lab_Solution_Bio_Co._Ltd-logo.jpg){kind=logo}
Provides pharma lab services, clinical trial analysis, and innovative diagnostic products.
South Korea
246250
South Korea
246250
A bioscience group offering clinical testing, supplements, and cosmetics for pharma/food industries.
Japan
2385
Japan
2385
Advancing gene therapies and technologies for rare neuromuscular and cardiac diseases.
United States of America
SLDB
United States of America
SLDB
Developing a high-precision, minimally invasive therapy for internal tumors like prostate cancer.
Sweden
SPEC
Sweden
SPEC
Develops & out-licenses preclinical oncology drugs for difficult-to-treat cancers.
Sweden
SPRINT
Sweden
SPRINT
Developing first-in-class therapies for serious, underserved neurological conditions like MPS IIIB.
United States of America
SPRB
United States of America
SPRB